These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 313292)

  • 1. T-cell markers in breast cancer patients at diagnosis.
    Goust JM; Roof BS; Fudenberg HH; O'Brien PH
    Clin Immunol Immunopathol; 1979 Apr; 12(4):396-403. PubMed ID: 313292
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tet60 and Tet18h rosette tests in breast cancer or Hodgkin's disease and in healthy persons].
    Gasińska A; Smolak K
    Nowotwory; 1980; 30(2):161-6. PubMed ID: 6968061
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

  • 5. "High-affinity" T-cell rosettes: the effects of clinical manipulations and potential prognostic significance.
    Weese JL; West WH; Herberman RB; Payne SM; Siwarski JW; Turcotte JG
    J Surg Oncol; 1980; 13(2):145-53. PubMed ID: 6965745
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous rosetting of human T lymphocytes with breast cancer cells.
    Kennett R; Seth R; Makgoba MW
    Int J Cancer; 1991 Sep; 49(2):317-9. PubMed ID: 1879975
    [No Abstract]   [Full Text] [Related]  

  • 7. Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma.
    Weese J; West W; Herberman R; Turcotte JG
    Surg Forum; 1977; 28():155-7. PubMed ID: 310169
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
    Shukla HS; Whitehead RH; Hughes LE
    Clin Oncol; 1980 Mar; 6(1):39-47. PubMed ID: 6966205
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferritin and depressed lymphocytes in breast cancer.
    Whitehead RH; Roberts GP; Worwood M
    N Engl J Med; 1978 Feb; 298(5):280. PubMed ID: 304178
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients.
    Jerrells TR; Dean JH; Herberman RB
    Int J Cancer; 1978 Mar; 21(3):282-90. PubMed ID: 305421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic response and prognosis in patients with breast cancer. II. Prognostic value of morphological and functional indicators of cellular response].
    Smolak K
    Nowotwory; 1984; 34(1):21-30. PubMed ID: 6330700
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific attachment of T-lymphocytes from cancer patients to tumor cells.
    Galili U; Caine M; Servadio C; Schlesinger M
    Cancer Lett; 1977 Sep; 3(3-4):121-4. PubMed ID: 302735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T acute lymphoblastic leukaemia with breast tumor. A brief report.
    Poros A; Hollán SR; Natonek K; Lelkes G; Gyódi E
    Haematologia (Budap); 1981; 14(2):215-8. PubMed ID: 6974118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of therapy on the lymphoid cell distribution in the venous blood of breast cancer patients].
    Heidenreich W; Jagla K; Börner P; Peter HH; Deinhardt J; Deicher H
    Onkologie; 1979 Oct; 2(5):188-92. PubMed ID: 395474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 20. T and B lymphocytes in cancer patients.
    Sengupta U; Dutta TK; Gupta BD; Aikat BK
    Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.